Abstract
Ying-Li Lin, Jian-Hua Ma, Xiang-Li Luo, et al. ‘Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer’, Journal of International Medical Research February 2013 vol. 41 no. 1 48–54. DOI: https://doi.org/10.1177/0300060513475571contains material which overlaps with a previously published article. Readers are referred to:YL Lin, ZG Li, ZK He, et al. ‘Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder Cancer’, Journal of International Medical Research December 2012 vol. 40 no. 6 2117–2123. DOI: 10.1177/030006051204000609 HF Zhang, KJ Zhao, PF Yang, et al. ‘Association between Fibroblast Growth Factor Receptor 4 Gly388Arg Polymorphism and Ischaemic Stroke’ Journal of International Medical Research October 2012 vol. 40 no. 5 1708–1714. DOI: https://doi.org/10.1177/030006051204000509contains material which overlaps with a previously published article. Readers are referred to:Lan Ma, Haifeng Zhang, Carrie Han, et al. ‘Fibroblast Growth Factor Receptor 4 Polymorphisms and Susceptibility to Coronary Artery Disease’ DNA and Cell Biology. June 2012, 31(6): 1064–1069. DOI: 10.1089/dna.2011.155 Bai H, Jing D, Guo A et al. ‘Association between interleukin 10 gene polymorphisms and risk of type 2 diabetes mellitus in a Chinese population’ Journal of International Medical Research June 2014 Vol. 42 no.3 702–710. DOI: https://doi.org/10.1177/0300060513505813.The first affiliation was listed incorrectly. It should have read:1First Affiliated Hospital of the General Hospital of the People’s Liberation Army, Beijing, ChinaThe authors apologise for this error.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
